NCT01579500View on ClinicalTrials.gov

Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Spinal Cord InjuryNeuropathic Pain
Interventions
DRUG

Botulinum toxin type A

Subcutaneous injection of botulinum toxin type A

DRUG

normal saline

Subcutaneous injection of normal saline

Trial Locations (1)

Unknown

Catholic University Saint Paul's Hospital; National Health Insurance Corporation Ilsan Hospital, Seoul

All Listed Sponsors
collaborator

National Health Insurance Service Ilsan Hospital

OTHER

collaborator

Medy-Tox

INDUSTRY

lead

Catholic University of Korea Saint Paul's Hospital

OTHER

NCT01579500 - Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients | Biotech Hunter | Biotech Hunter